ਸਟੈਮ ਸੈੱਲ ਟ੍ਰਾਂਸਪਲਾਂਟ ਤੋਂ ਬਾਅਦ ਦੀ ਦੇਖਭਾਲ
Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients
ਕਿੱਥੇ ਜਾਣਾ ਹੈ
ਇਸ ਟਰਾਇਲ ਲਈ ਇੰਡੀਆ ਵਿੱਚ 2 ਹਸਪਤਾਲ ਮਰੀਜ਼ ਲੈ ਰਹੇ ਹਨ।
ਰਜਿਸਟਰੀ ਸਮਰੀ (ਤਕਨੀਕੀ)
What is acute Graft versus host disease (aGvHD)? GvHD is a complication that can occur after an allogeneic stem cell transplant resulting in damage to some organs. The death rate of GvHD patients is 15-40%. In GvHD, the donated peripheral blood stem cells or bone marrow view the recipient's body as foreign, and the donated cells/bone marrow harm the body. aGvHD usually develops in skin, liver or gastrointestinal tract, and symptoms might appear within few weeks after transplant. Symptoms of acute GvHD are observed as skin rash or reddened areas on the skin, yellow discoloration of the skin and…
Sponsor: Tata Memorial Centre
NCT07724873 on ClinicalTrials.gov
ਰਜਿਸਟਰੀ 'ਤੇ ਆਖਰੀ ਵਾਰ 24 Jul 2026 ਨੂੰ ਅਪਡੇਟ ਕੀਤਾ ਗਿਆ · ਅਸੀਂ 20 Oct 2026 ਨੂੰ ਪੜ੍ਹਿਆ